Desq Long
Sign in

Company

Caris Life Sciences, Inc.

CAI · CIK 0002019410

SEC FORM 4
$238,626.00

Caris Life Sciences, Inc. (CAI)

Sale of 7,500 shares at $31.8168 per share.

Reporting Person Denton John Russel · Officer Title See Remarks · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 23, 2026

Source: SEC Form 4 · 0002071923-26-000007 · filed 2026-09-23 · View filing →

SEC FORM 4
$976,000.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code M) of 400,000 shares at $2.44 per share.

Reporting Person Brille Brian J · Officer Title See Remarks · Transaction Code M

Traded Sep 17, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0002071959-26-000008 · filed 2026-09-17 · View filing →

SEC FORM 4
$12,132,080.00

Caris Life Sciences, Inc. (CAI)

Sale of 400,000 shares at $30.3302 per share.

Reporting Person Brille Brian J · Officer Title See Remarks · Transaction Code S

Traded Sep 17, 2026 · Disclosed Sep 17, 2026

Source: SEC Form 4 · 0002071959-26-000008 · filed 2026-09-17 · View filing →

SEC FORM 4
$610,000.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code M) of 250,000 shares at $2.44 per share.

Reporting Person Spetzler David Baxley · Officer Title President · Transaction Code M

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002071953-26-000007 · filed 2026-09-04 · View filing →

SEC FORM 4
$2,951,116.90

Caris Life Sciences, Inc. (CAI)

Sale of 119,212 shares at $24.7552 per share.

Reporting Person Spetzler David Baxley · Officer Title President · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002071953-26-000007 · filed 2026-09-04 · View filing →

SEC FORM 4
$2,440,000.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code M) of 1,000,000 shares at $2.44 per share.

Reporting Person Spetzler David Baxley · Officer Title President · Transaction Code M

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002071953-26-000007 · filed 2026-09-04 · View filing →

SEC FORM 4
$9,733,313.24

Caris Life Sciences, Inc. (CAI)

Sale of 393,100 shares at $24.7604 per share.

Reporting Person Spetzler David Baxley · Officer Title President · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002071953-26-000007 · filed 2026-09-04 · View filing →

SEC FORM 4
$2,149,676.49

Caris Life Sciences, Inc. (CAI)

Sale of 84,900 shares at $25.3201 per share.

Reporting Person Spetzler David Baxley · Officer Title President · Transaction Code S

Traded Sep 3, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0002071953-26-000007 · filed 2026-09-04 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person HALBERT JON · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001189394-26-000008 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person JOHANSEN LAURA I · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001189395-26-000002 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person CASTLEMAN PETER M · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001239594-26-000008 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person PHILLIPS T DANNY · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001239690-26-000005 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person Gilliam Joseph E · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001705850-26-000025 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person Vacirca Jeff L · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0001724161-26-000008 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person Minor Lloyd · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0002038687-26-000007 · filed 2026-08-14 · View filing →

SEC FORM 4
$0.00

Caris Life Sciences, Inc. (CAI)

Acquisition (code A) of 13,192 shares at $0 per share.

Reporting Person Fredrickson David Paul · Transaction Code A

Traded Aug 14, 2026 · Disclosed Aug 14, 2026

Source: SEC Form 4 · 0002071948-26-000005 · filed 2026-08-14 · View filing →